Julio A. Yanes

Julio A. Yanes

Auto-generated profile, based on publicly available information

Julio A. Yanes

Duke University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2021 in Pain
Verified
Journal Article
Open access
NSNadia Soliman
Nadia Soliman
SHSimon Haroutounian
Simon Haroutounian
AHAndrea G. Hohmann
Andrea G. Hohmann
EKElliot Krane
Elliot Krane
JLJing Liao
Jing Liao
ARAndrew S.C. Rice
Andrew S.C. Rice
We report a systematic review and meta-analysis of studies which assessed the antinociceptive efficacy of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators on pain-associated behavioural outcomes in animal models of pathological or injury-related persistent pain. In April 2019, we systematically searched 3 online databases and used crowd science and machine learning to identify studies for inclusion. We calculated a standardised mean difference (SMD) effect size for each comparison and performed a random effects meta-analysis. We assessed the impact of study design characteristics and reporting of mitigations to reduce the risk of bias. We meta-analysed 374 studies in which 171 interventions were assessed for antinociceptive efficacy in rodent models of pathological or injury-related pain. Most experiments were conducted in male animals (86 %). Antinociceptive efficacy was most frequently measured by attenuation of hypersensitivity to evoked limb withdrawal. Selective CB1, CB2, non-selective cannabinoid receptor agonists (including delta-9-tetrahydrocannabinol; THC), and PPAR-alpha agonists (predominantly palmitoylethanolamide; PEA) significantly attenuated pain-associated behaviours in a broad range of inflammatory and neuropathic pain models. Fatty acid amide hydrolase (FAAH) inhibitors, monoacylglycerol lipase (MGL) inhibitors and cannabidiol (CBD) significantly attenuated pain-associated behaviours in neuropathic pain models but yielded mixed results in inflammatory pain models. The reporting of criteria to reduce the risk of bias was low, therefore the studies have an unclear risk of bias. The value of future studies could be enhanced by improving the reporting of methodological criteria, the clinical relevance of the models and behavioural assessments. Notwithstanding, the evidence supports the hypothesis of cannabinoid-induced analgesia.

17 January 2018 in Journal of Psychopharmacology
Verified
Journal Article
Open access
PDF file
JYJulio A Yanes
Julio A Yanes
MRMichael C Riedel
Michael C Riedel
KRKimberly L Ray
Kimberly L Ray
AKAnna Kirkland
Anna Kirkland
RBRyan T Bird
Ryan T Bird
MSMatthew Sutherland
Matthew Sutherland
Lagging behind rapid changes to state laws, societal views, and medical practice is the scientific investigation of cannabis’s impact on the human brain. While several brain imaging studies have contributed important insight into neurobiological alterations linked with cannabis use, our understanding remains limited. Here, we sought to delineate those brain regions that consistently demonstrate functional alterations among cannabis users versus non-users across neuroimaging studies using the activation likelihood estimation meta-analysis framework. In ancillary analyses, we characterized task-related brain networks that co-activate with cannabis-affected regions using data archived in a large neuroimaging repository, and then determined which psychological processes may be disrupted via functional decoding techniques. When considering convergent alterations among users, decreased activation was observed in the anterior cingulate cortex, which co-activated with frontal, parietal, and limbic areas and was linked with cognitive control processes. Similarly, decreased activation was observed in the dorsolateral prefrontal cortex, which co-activated with frontal and occipital areas and linked with attention-related processes. Conversely, increased activation among users was observed in the striatum, which co-activated with frontal, parietal, and other limbic areas and linked with reward processing. These meta-analytic outcomes indicate that cannabis use is linked with differential, region-specific effects across the brain.

13 June 2022
Verified
Journal Article
Open access
PDF file
TSTaylor Salo
Taylor Salo
TYTal Yarkoni
Tal Yarkoni
TNThomas E. Nichols
Thomas E. Nichols
JPJean-Baptiste Poline
Jean-Baptiste Poline
MBMurat Bilgel
Murat Bilgel
ALAngela R. Laird
Angela R. Laird

31 July 2019 in Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
JYJulio A. Yanes
Julio A. Yanes

20 April 2022 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
JYJulio A. Yanes
Julio A. Yanes
TATitilola Akintola
Titilola Akintola

4 April 2023 in The Journal of Pain
Verified
Journal Article
Closed access
JPJulie Parsons
Julie Parsons
SBSabrina Barhoum
Sabrina Barhoum
MDMaya Joshi Delity
Maya Joshi Delity
JBJama Brookes
Jama Brookes
TATitilola Akintola
Titilola Akintola
LALauren Atlas
Lauren Atlas